Phase II Trial of Neoadjuvant Exemestane in Combination With Celecoxib in Postmenopausal Women Who Have Breast Cancer

PURPOSE: Within breast tissue, aromatase expression and activity is increased by prostaglandin E2, providing a rationale for combining the COX-2 inhibitor celecoxib with an aromatase inhibitor. To evaluate the effect of these drugs on aromatase and other biomarkers, a phase II trial of neoadjuvant e...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lustberg, Maryam B., Povoski, Stephen P., Zhao, Weiqiang, Ziegler, Rebecca M., Sugimoto, Yasuro, Ruppert, Amy S., Lehman, Amy M., Shiels, Donna R., Mrozek, Ewa, Ramaswamy, Bhuvaneswari, Layman, Rachel M., Brueggemeier, Robert W., Shapiro, Charles L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3440773/
https://ncbi.nlm.nih.gov/pubmed/21729671
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clbc.2011.03.022
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados